Mechanistic Modeling of Radium-223 Treatment of Bone Metastases

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Chris Parker, Sten Nilsson, Daniel Heinrich et al. · New England Journal of Medicine · 2013 · 3.3K citations

Medicine, Nuclear Medicine, Radiation Oncology +17

MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy

George Sgouros, John C. Roeske, Michael R. McDevitt et al. · Journal of Nuclear Medicine · 2010 · 533 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with ²²⁵Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding

Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke et al. · Journal of Nuclear Medicine · 2017 · 496 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial

Oliver Sartor, Robert L. Coleman, Sten Nilsson et al. · The Lancet Oncology · 2014 · 491 citations

Medicine, Oncology, Pharmacology +17

Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides.

John A. O'Donoghue, Manuel Bardiès, T. E. Wheldon · PubMed · 1995 · 378 citations

Medicine, Nuclear Medicine, Oncology +17